Susan Hasty, Publisher
Table of Contents . . . December 25th, 1995Non-Subscriber - Summaries Only
Infection Control - TB and AIDS Programs - Natural Partners or Not?
Animal Models - Mouse Model Useful for Determining TB Pathology
Conference Coverage (ACTG) - "New" ACTG Moves Forward
Conference Coverage (ACTG) - Patient Recruitment and Retention a Problem for ACTG
Disease Markers - Increased Soluble CD14 Useful Marker in TB Patients
Drug Screening - Particle Counting Assay Evaluates TB Drugs
Epidemiology (TB) - Old Infection May Be Responsible for Clustered TB in Arkansas
Occupational Exposure (TB) - Most TB in New York HCWs Due to Recent Infections
Occupational Exposure (TB) - Product Simplifies Compliance with Guidelines for TB Exposure
Pediatrics - Hepatic Toxicity Reversible in TB-Treated Children
Prophylaxis (TB) - Isoniazid-Based Therapy Useful Despite Hepatotoxicity
Diagnostics (TB) - "CT in Craniovertebral Tuberculosis."
Diagnostics (TB) - "Effect of HIV Status on Chest CT Findings In Patients with Tuberculosis."
Diagnostics (TB) - "Imaging and Intervention of Genitourinary Tuberculosis: Revisited."
Diagnostics (TB) - "Musculoskeletal Tuberculosis: MR Imaging Manifestations."
Immunology (TB) - "Regulation of the Human Cellular Immune Response in Tuberculosis."
Infection Control (TB) - "Behavioral Factors in Tuberculosis Control."
Pharmacoeconomics - "Cost Effectiveness of Antituberculosis Interventions."
Therapy (Hepatotoxicity) - "Aging and Hepatotoxicity of Isoniazid and Rifampin in Pulmonary Tuberculosis."
Therapy (Hepatotoxicity) - "Hepatotoxicity from Isoniazid and Rifampin in Inner-City AIDS Patients."